Structure and physiology of the RET receptor tyrosine kinase

Cold Spring Harbor Perspectives in Biology

Volumn 5, Issue 2, 2013, Pages

  Ibáñez, Carlos F ^a,b  

^a KAROLINSKA INSTITUTE   (Sweden)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

LIGAND; PROTEIN RET;

ANIMAL; ARTICLE; CELL STRAIN 3T3; CELL TRANSFORMATION; CHEMISTRY; GENE REARRANGEMENT; HUMAN; KIDNEY; MOLECULAR EVOLUTION; MOUSE; NERVOUS SYSTEM; PHYSIOLOGY; PRENATAL DEVELOPMENT; PROTEIN TERTIARY STRUCTURE; SIGNAL TRANSDUCTION;

ANIMALS; CELL TRANSFORMATION, NEOPLASTIC; EVOLUTION, MOLECULAR; GENE REARRANGEMENT; HUMANS; KIDNEY; LIGANDS; MICE; NERVOUS SYSTEM; NIH 3T3 CELLS; PROTEIN STRUCTURE, TERTIARY; PROTO-ONCOGENE PROTEINS C-RET; SIGNAL TRANSDUCTION;

EID: 84875192416     PISSN: None     EISSN: 19430264     Source Type: Journal    
DOI: 10.1101/cshperspect.a009134     Document Type: Article

References (88)

1. Abrescia C, Sjöstrand D, Kjaer S, Ibanez CF. 2005. Drosophila RET contains an active tyrosine kinase and elicits neuro- trophic activities in mammalian cells. FEBS Lett 579: 3789-3796.
2. Amoresano A, Incoronato M, Monti G, Pucci P, de Franciscis V, Cerchia L. 2005. Direct interactions among Ret, GDNF and GFRa1 molecules reveal new insights into the assembly of a functional three-protein complex. Cell Signal 17: 717-727.
3. Anders J, Kjar S, Ibanez CF. 2001. Molecular modeling of the extracellular domain of the RETreceptor tyrosine kinase reveals multiple cadherin-like domains and a calcium- binding site. J Biol Chem 276: 35808-35817.
4. Aron L, Klein R. 2011. Repairing the parkinsonian brain with neurotrophic factors. Trends Neurosci 34: 88-100.
5. Asai N, Fukuda T, Wu Z, Enomoto A, Pachnis V, Takahashi M, Costantini F. 2006. Targeted mutation of serine 697 in the Ret tyrosine kinase causes migration defect of enteric neural crest cells. Development 133: 4507-4516.
6. Baloh RH, Tansey MG, Golden JP, Creedon DJ, Heuckeroth RO, Keck CL, Zimonjic DB, Popescu NC, Johnson EM, Milbrandt J. 1997. TrnR2, a novel receptor that mediates neurturin and GDNF signaling through Ret. Neuron 18: 793-802.
7. Baloh RH, Gorodinsky A, Golden JP, Tansey MG, Keck CL, Popescu NC, Johnson EM, Milbrandt J. 1998a. GFRa3 is an orphan member of the GDNF/neurturin/persephin receptor family. Proc Natl Acad Sci 95: 5801-5806.
8. Baloh RH, Tansey MG, Lampe PA, Fahrner TJ, Enomoto H, Simburger KS, Leitner ML, Araki T, Johnson EM, Milbrandt J. 1998b. Artemin, a novel member of the GDNF ligand family, supports peripheral and central neurons and signals through the GFRa3-RET receptor complex. Neuron 21: 1291-1302.
9. Bespalov MM, Sidorova YA, Tumova S, Ahonen-Bishopp A, Magalhães AC, Kulesskiy E, Paveliev M, Rivera C, Rauvala H, Saarma M. 2011. Heparan sulfate proteogly- can syndecan-3 is a novel receptor for GDNF, neurturin, and artemin. J Cell Biol 192: 153-169.
10. Besset V, Scott RP, Ibanez CF. 2000. Signaling complexes and protein-protein interactions involvedinthe activation of the Ras and phosphatidylinositol 3-kinase pathways by the c-Ret receptor tyrosine kinase. J Biol Chem 275: 39159-39166.
11. Bordeaux MC, Forcet C, Granger L, Corset V, Bidaud C, Billaud M, Bredesen DE, Edery P, Mehlen P. 2000. The RET proto-oncogene induces apoptosis: A novel mech- anism for Hirschsprung disease. EMBO J 19: 4056-4063.
12. Borrello MG, Alberti L, Arighi E, Bongarzone I, Battistini C, Bardelli A, Pasini B, Piutti C, Rizzetti MG, Mondellini P, et al. 1996. The full oncogenic activity of Ret/ptc2 de- pends on tyrosine 539, a docking site for phospholipase Cg. Mol Cell Biol 16: 2151-2163.
13. Buj-Bello A, Adu J, Pin ̃o ́n LG, Horton A, Thompson JF, Rosenthal A, Chinchetru M, Buchman VL, Davies AM. 1997. Neurturin responsiveness requires a GPI-linked re- ceptor and the Ret receptor tyrosine kinase. Nature 387: 721-724.
14. Cik M, Masure S, Lesage AS, Van der Linden I, Van Gompel P, Pangalos MN, Gordon RD, Leysen JE. 2000. BindingofGDNFand neurturintohuman GDNF family receptor a 1 and 2. Influence of cRET and cooperative interactions. J Biol Chem 275: 27505-27512.
15. Cosma MP, Cardone M, Carlomagno F, Colantuoni V. 1998. Mutations in the extracellular domain cause RET loss of function by a dominant negative mechanism. Mol Cell Biol 18: 3321-3329.
16. Coulpier M, Anders J, Ibanez CF. 2002. Coordinated activation of autophosphorylation sites in the RET receptor tyrosine kinase: Importance of tyrosine 1062 for GDNF mediated neuronal differentiation and survival. J Biol Chem 277: 1991-1999.
17. Crowder R, Enomoto H, Yang M, Johnson E, Milbrandt J. 2004. Dok-6, a novel p62 Dok family member, promotes Ret-mediated neurite outgrowth. J Biol Chem 279: 42072-42081.
18. de Graaff E, Srinivas S, Kilkenny C, D'Agati V, Mankoo BS, Costantini FD, Pachnis V. 2001. Differential activities of the RET tyrosine kinase receptor isoforms during mam- malian embryogenesis. Genes Dev 15: 2433-2444.
19. Donis-Keller H, Dou S, Chi D, Carlson KM, Toshima K, Lairmore TC, Howe JR, Moley JF, Goodfellow P, Wells SA. 1993. Mutations in the RET proto-oncogene are associated with MEN 2A and FMTC. Hum Mol Genet 2: 851-856.
20. Durbec P, Marcos-Gutierrez CV, Kilkenny C, Grigoriou M, Wartiowaara K, Suvanto P, Smith D, Ponder B, Costantini FD, Saarma M, et al. 1996. GDNF signalling through the Ret receptor tyrosine kinase. Nature 381: 789-793.
21. Eketjäll S, Fainzilber M, Murray-Rust J, Ibanez CF. 1999. Distinct structural elements in GDNF mediate binding to GFRa1 and activation of the GFRa1-c-Ret receptor complex. EMBO J 18: 5901-5910.
22. Encinas M, Crowder RJ, Milbrandt J, Johnson EM. 2004. Tyrosine 981, a novel ret autophosphorylation site, binds c-Src to mediate neuronal survival. J Biol Chem 279: 18262-18269.
23. Fukuda T, Kiuchi K, Takahashi M. 2002. Novel mechanism of regulation of Rac activity and lamellipodia formation by RET tyrosine kinase. J Biol Chem 277: 19114-19121.
24. Garcés A, Haase G, Airaksinen MS, Livet J, Filippi P, Delapeyriére O. 2000. GFRa 1 is required for development of distinct subpopulations of motoneuron. J Neurosci 20: 4992-5000.
25. Geneste O, Bidaud C, De Vita G, Hofstra RM, Tartare-Deckert S, Buys CH, Lenoir GM, Santoro M, Billaud M. 1999. Two distinct mutations of the RETreceptor causing Hirschsprung's disease impair the binding of signalling effectors to a multifunctional docking site. Hum Mol Genet 8: 1989-1999.
26. Gould TW, Yonemura S, Oppenheim RW, Ohmori S, Enomoto H. 2008. The neurotrophic effects of glial cell line- derived neurotrophic factor on spinal motoneurons are restricted to fusimotor subtypes. J Neurosci 28: 2131-2146.
27. Grieco M, Santoro M, Berlingieri MT, Melillo RM, Donghi R, Bongarzone I, Pierotti MA, Porta Della G, Fusco A, Vecchio G. 1990. PTC is a novel rearranged form of the ret proto-oncogene and is frequently detected in vivo in human thyroid papillary carcinomas. Cell 60: 557-563.
28. Grimm J, Sachs M, Britsch S, Di Cesare S, Schwarz-Romond T, Alitalo K, Birchmeier W. 2001. Novel p62dok family members, dok-4 and dok-5, are substrates of the c-Ret receptor tyrosine kinase and mediate neu- ronal differentiation. J Cell Biol 154: 345-354.
29. Hahn M, Bishop J. 2001. Expression pattern of Drosophila ret suggests acommon ancestral origin between the meta- morphosis precursors in insect endoderm and the verte- brate enteric neurons. Proc Natl Acad Sci 98: 1053-1058.
30. Hayashi H, Ichihara M, Iwashita T, Murakami H, Shimono Y, Kawai K, Kurokawa K, Murakumo Y, Imai T, Funahashi H, et al. 2000. Characterization of intracellular signals via tyrosine 1062 in RET activated by glial cell line-derived neurotrophic factor. Oncogene 19: 4469-4475.
31. Henderson C, Phillips H, Pollock R, Davies A, Lemeulle C, Armanini M, Simpson L, Moffet B, Vandlen R, Koliatsos V, et al. 1994. Gdnf: A potent survival factor for motoneurons present in peripheral-nerve and muscle. Science 266: 1062-1064.
32. Hofstra RM, Landsvater RM, Ceccherini I, Stulp RP, Stelwagen T, Luo Y, Pasini B, Höppener JW, van Amstel HK, Romeo G. 1994. A mutation in the RET proto-oncogene associated with multiple endocrine neoplasia type 2Band sporadic medullary thyroid carcinoma. Nature 367: 375- 376.
33. Ibanez CF. 2008. Catecholaminergic neuron survival: Getting hooked on GDNF. Nat Neurosci 11: 735-736.
34. Iwamoto T, Taniguchi M, Asai N, Ohkusu K, Nakashima I, Takahashi M. 1993. cDNA cloning of mouse ret proto- oncogene and its sequence similarity to the cadherin superfamily. Oncogene 8: 1087-1091.
35. Iwashita T, Murakami H, Asai N, Takahashi M. 1996. Mechanism of ret dysfunction by Hirschsprung mutations affecting its extracellular domain. Hum Mol Genet 5: 1577-1580.
36. Jain S, Encinas M, Johnson EM, Milbrandt J. 2006a. Critical and distinct roles for key RET tyrosine docking sites in renal development. Genes Dev 20: 321-333.
37. Jain S, Golden JP, Wozniak D, Pehek E, Johnson EM, Milbrandt J. 2006b. RET is dispensable for maintenance of midbrain dopaminergic neurons in adult mice. J Neu- rosci 26: 11230-11238.
38. Jiao L, Zhang Y, Hu C, Wang Y-G, Huang A, He C. 2011. Rap1GAP interacts with RET and suppresses GDNF-induced neurite outgrowth. Cell Res 21: 327-337.
39. Jijiwa M, Fukuda T, Kawai K, Nakamura A, Kurokawa K, Murakumo Y, Ichihara M, Takahashi M.2004. Atargeting mutation of tyrosine 1062 in Ret causes a marked de- crease of enteric neurons and renal hypoplasia. Mol Cell Biol 24: 8026-8036.
40. Jing S, Wen D, Yu Y, Holst PL, Luo Y, Fang M, Tamir R, Antonio L, Hu Z, Cupples R, et al. 1996. GDNF-induced activation of the ret protein tyrosine kinase is mediated by GDNFR-a, a novel receptor for GDNF. Cell 85: 1113-1124.
41. Kawamoto Y, Takeda K, Okuno Y, Yamakawa Y, Ito Y, Taguchi R, Kato M, Suzuki H, Takahashi M, Nakashima I. 2004. Identification of RETautophosphorylation sites by mass spectrometry. J Biol Chem 279: 14213-14224.
42. Kjaer S, Ibanez CF. 2003a. Identification of a surface for binding to the GDNF-GFR a 1 complex in the first cad- herin-like domain of RET. J Biol Chem 278: 47898-47904.
43. Kjaer S, Ibanez CF. 2003b. Intrinsic susceptibility to misfolding of a hot-spot for Hirschsprung disease mutations in the ectodomain of RET. Hum Mol Genet 12: 2133- 2144.
44. Kjaer S, Kurokawa K, Perrinjaquet M, Abrescia C, Ibanez CF. 2006. Self-association of the transmembrane domain of RET underlies oncogenic activation by MEN2A mutations. Oncogene 25: 7086-7095.
45. Kjaer S, Heilshorn S, Totty N, McDonald NQ. 2010. Mammal-restricted elements predispose human RET to fold- ing impairment by HSCR mutations. Nat Struct Biol 17: 726-731.
46. Klein RD, Sherman D, Ho WH, Stone D, Bennett GL, Moffat B, Vandlen R, Simmons L, Gu Q, Hongo JA, et al. 1997. A GPI-linked protein that interacts with Ret to form a candidate neurturin receptor. Nature 387: 717-721.
47. Knowles PP, Murray-Rust J, Kjaer S, Scott RP, Heilshorn S, Santoro M, Ibanez CF, McDonald NQ. 2006. Structure and chemical inhibition of the RET tyrosine kinase domain. J Biol Chem 281: 33577-33587.
48. Kotzbauer PT, Lampe PA, Heuckeroth RO, Golden JP, Creedon DJ, Johnson EM, Milbrandt J. 1996. Neurturin, a relative of glial-cell-line-derived neurotrophic factor. Nature 384: 467-470.
49. Kramer ER, Knott L, Su F, Dessaud E, Krull CE, Helmbacher F, Klein R. 2006. Cooperation between GDNF/ Ret and ephrinA/EphA4 signals for motor-axon pathway selection in the limb. Neuron 50: 35-47.
50. Kramer, Aron L, Ramakers, Seitz, Zhuang, Beyer, Smidt, Klein. 2007. Absence of Ret signaling in mice causes pro- gressive and late degeneration of the nigrostriatal system. PLoS Biol 5: e39.
51. Kurokawa K, Iwashita T, Murakami H, Hayashi H, Kawai K, Takahashi M. 2001. Identification of SNT/FRS2 docking site on RETreceptor tyrosine kinase and its role for signal transduction. Oncogene 20: 1929-1938.
52. Kurotsuchi A, Murakumo Y, Jijiwa M, Kurokawa K, Itoh Y, Kodama Y, Kato T, Enomoto A, Asai N, Terasaki H, et al. 2010. Analysis of DOK-6 function in downstream signaling of RET in human neuroblastoma cells. Cancer Sci 101: 1147-1155.
53. Lin LF, Doherty DH, Lile JD, Bektesh S, Collins F. 1993. GDNF: A glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons. Science 260: 1130-1132.
54. Liu X, Vega QC, Decker RA, Pandey A, Worby CA, Dixon JE. 1996. Oncogenic RET receptors display different auto- phosphorylation sites and substrate binding specificities. J Biol Chem 271: 5309-5312.
55. Lundgren TK, Scott RP, Smith M, Pawson T, Ernfors P. 2006. Engineering the recruitment of phosphotyrosine binding domain-containing adaptor proteins reveals distinct roles for RET receptor-mediated cell survival. J Biol Chem 281: 29886-29896.
56. Massagué J. 1996. Neurotrophic factors. Crossing receptor boundaries. Nature 382: 29-30.
57. Masure S, Cik M, Hoefnagel E, Nosrat CA, Van der Linden I, Scott RP, Van Gompel P, Lesage AS, Verhasselt P, Ibanez CF, et al. 2000. Mammalian GFRa-4, a divergent member of the GFRa family of coreceptors for glial cell line-derived neurotrophic factor family ligands, is a re- ceptor for the neurotrophic factor persephin. J Biol Chem 275: 39427-39434.
58. Melillo RM, Santoro M, Ong SH, Billaud M, Fusco A, Hadari YR, Schlessinger J, Lax I. 2001. Docking protein FRS2 links the protein tyrosine kinase RETand its oncogenic forms with the mitogen-activated protein kinase signaling cascade. Mol Cell Biol 21: 4177-4187.
59. Mijatovic J, Airavaara M, Planken A, Auvinen P, Raasmaja A, Piepponen TP, Costantini FD, Ahtee L, Saarma M. 2007. Constitutive Ret activity in knock-in multiple endocrine neoplasia type B mice induces profound elevation of brain dopamine concentration via enhanced synthesis and increases the numberof TH-positive cells in the sub- stantia nigra. J Neurosci 27: 4799-4809.
60. Milbrandt J, de Sauvage FJ, Fahrner TJ, Baloh RH, Leitner ML, Tansey MG, Lampe PA, Heuckeroth RO, Kotzbauer PT, Simburger KS, et al. 1998. Persephin, a novel neurotrophic factor related to GDNF and neurturin. Neuron 20: 245-253.
61. Mulligan LM, Kwok JB, Healey CS, Elsdon MJ, Eng C, Gardner E, Love DR, Mole SE, Moore JK, Papi L. 1993. Germ-line mutationsof the RET proto-oncogenein multiple endocrine neoplasia type 2A. Nature 363: 458-460.
62. Naveilhan P, Baudet C, Mikaels A, Shen L, Westphal H, Ernfors P. 1998. Expression and regulation of GFRa3, a glial cell line-derived neurotrophic factor family receptor. Proc Natl Acad Sci 95: 1295-1300.
63. Nollet F, Kools P, van Roy F. 2000. Phylogenetic analysis of the cadherin superfamily allows identification of six ma- jor subfamilies besides several solitary members. J Mol Biol 299: 551-572.
64. Oppenheim RW, Houenou LJ, Parsadanian AS, Prevette D, Snider WD, Shen L. 2000. Glial cell line-derived neurotrophic factor and developing mammalian motoneurons: Regulation of programmed cell death among motoneu- ron subtypes. J Neurosci 20: 5001-5011.
65. Pachnis V, Mankoo B, Costantini FD. 1993. Expression of the c-ret proto-oncogene during mouse embryogenesis. Development 119: 1005-1017.
66. Paratcha G, Ledda F, Baars L, Coulpier M, Besset V, Anders J, Scott RP, Ibanez CF. 2001. Released GFRa1 potentiates downstream signaling, neuronal survival, and differentiation via a novel mechanism of recruitment of c-Ret to lipid rafts. Neuron 29: 171-184.
67. Paratcha G, Ledda F, Ibanez CF. 2003. The neural cell adhesion molecule NCAM is an alternative signaling receptor for GDNF family ligands. Cell 113: 867-879.
68. Pascual A, Hidalgo-Figueroa M, Piruat JI, Pintado CO, Gómez-Díaz R, López-Barneo J. 2008. Absolute require- ment of GDNF for adult catecholaminergic neuron survival. Nat Neurosci 11: 755-761.
69. Pelet A, Geneste O, Edery P, Pasini A, Chappuis S, Atti T, Munnich A, Lenoir G, Lyonnet S, Billaud M. 1998. Var- ious mechanisms cause RET-mediated signaling defects in Hirschsprung's disease. J Clin Invest 101: 1415-1423.
70. Perrinjaquet M, Vilar M, Ibanez CF. 2010. Protein-tyrosine phosphatase SHP2 contributes to GDNF neurotrophic activity through direct binding to phospho-Tyr687 in the RET receptor tyrosine kinase. J Biol Chem 285: 31867-31875.
71. Sanicola M, Hession CA, Worley D, Carmillo P, Ehrenfels C, Walus L, Robinson S, Jaworski G, Wei H, Tizard R, et al. 1997. Glial cell line-derived neurotrophic factor-dependent RETactivation can be mediated by two different cell- surface accessory proteins. Proc Natl Acad Sci 94: 6238-6243.
72. Santoro M, Carlomagno F. 2013. Central role of RET in thyroid cancer. Cold Spring Harb Perspect Biol doi: 10.1101/cshperspect.a009233.
73. Schuchardt A, D'Agati V, Larsson-Blomberg L, Costantini FD, Pachnis V. 1994. Defects in the kidney and enteric nervous system of mice lacking the tyrosine kinase receptor Ret. Nature 367: 380-383.
74. Schuchardt A, D'Agati V, Pachnis V, Costantini F. 1996. Renal agenesis and hypodysplasia in ret-k- mutant mice result from defects in ureteric bud development. Development 122: 1919-1929.
75. Schuetz G, Rosário M, Grimm J, Boeckers TM, Gundelfinger ED, Birchmeier W. 2004. The neuronal scaffold protein Shank3 mediates signaling and biological function of the receptor tyrosine kinase Ret in epithelial cells. J Cell Biol 167: 945-952.
76. Segouffin-Cariou C, Billaud M. 2000. Transforming ability of MEN2A-RET requires activation of the phosphatidy- linositol 3-kinase/AKT signaling pathway. J Biol Chem 275: 3568-3576.
77. Shakya R, Watanabe T, Costantini FD. 2005. The role of GDNF/Ret signaling in ureteric bud cell fate and branch- ing morphogenesis. Dev Cell 8: 65-74.
78. Takahashi M, Cooper GM. 1987. ret transforming gene encodes a fusion protein homologous to tyrosine kinases. Mol Cell Biol 7: 1378-1385.
79. Takahashi M, Ritz J, Cooper GM. 1985. Activation of a novel human transforming gene, ret, by DNA rearrangement. Cell 42: 581-588.
80. Takahashi M, Buma Y, Iwamoto T, Inaguma Y, Ikeda H, Hiai H. 1988. Cloning and expression of the ret protooncogene encoding a tyrosine kinase with two potential transmembrane domains. Oncogene 3: 571-578.
81. Taraviras S, Marcos-Gutierrez CV, Durbec P, Jani H, Grigoriou M, Sukumaran M, Wang LC, Hynes MA, Raisman G, Pachnis V. 1999. Signalling by the RET receptor tyrosine kinase and its role in the development of the mammalian enteric nervous system. Development 126: 2785-2797.
82. Trupp M, Arenas E, Fainzilber M, Nilsson AS, Sieber B-A, Grigoriou M, Kilkenny C, Salazar-Grueso E, Pachnis V, Arumae U, et al. 1996. Functional receptor for GDNF encoded by the c-ret proto-oncogene. Nature 381: 785-789.
83. Trupp M, Belluardo N, Funakoshi H, Ibanez CF. 1997. Complementary and overlapping expression of glial cell line- derived neurotrophic factor (GDNF), c-ret proto-oncogene, and GDNF receptor-a indicates multiple mechanisms of trophic actions in the adult rat CNS. J Neurosci 17: 3554-3567.
84. Trupp M, Raynoschek C, Belluardo N, Ibanez CF. 1998. Multiple GPI-anchored receptors control GDNF-dependent and independent activation of the c-Ret receptor tyrosine kinase. Mol Cell Neurosci 11: 47-63.
85. Uesaka T, Jain S, Yonemura S, Uchiyama Y, Milbrandt J, Enomoto H. 2007. Conditional ablation of GFRa1 in postmigratory enteric neurons triggers unconventional neuronal death in the colon and causes a Hirschsprung's disease phenotype. Development 134: 2171-2181.
86. Uesaka T, Nagashimada M, Yonemura S, Enomoto H. 2008. Diminished Ret expression compromises neuronal survival in the colon and causes intestinal aganglionosis in mice. J Clin Invest 118: 1890-1898.
87. Wong A, Bogni S, Kotka P, de Graaff E, D'Agati V, Costantini FD, Pachnis V. 2005. Phosphotyrosine 1062 is critical for the in vivo activity of the Ret9 receptor tyrosine kinase isoform. Mol Cell Biol 25: 9661-9673.
88. Worby CA, Vega QC, Chao HH, Seasholtz AF, Thompson RC, Dixon JE. 1998. Identification and characterizationof GFRa-3,anovel co-receptor belongingto the glial cell line-derived neurotrophic receptor family. J Biol Chem 273: 3502-3508.